Clearstead Trust’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.9K Buy
74
+9
+14% +$3.81K ﹤0.01% 400
2026
Q1
$30.8K Hold
65
0.01% 370
2025
Q4
$30.3K Sell
65
-5
-7% -$2.32K ﹤0.01% 389
2025
Q3
$29.8K Hold
70
0.01% 378
2025
Q2
$26.8K Buy
70
+53
+312% +$19.1K 0.01% 379
2025
Q1
$5.88K Buy
+17
New +$5.47K ﹤0.01% 566
2017
Q3
Sell
-1,357
Closed -$118K 224
2017
Q2
$118K Buy
+1,357
New +$115K 0.09% 119

Other funds holding HCA

Clearstead Trust's HCA Position: Q2 2026 in Review

Clearstead Trust increased its HCA Healthcare (HCA) stake by 14% in Q2 2026, buying an estimated $3.81K and bringing the position to 74 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #400.

Clearstead Trust first reported a position in HCA in Q2 2017 and has held it in 7 quarters since. The position peaked at $118K in Q2 2017. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Clearstead Trust held 74 shares of HCA Healthcare worth $28.9K as of Q2 2026.
  • Clearstead Trust bought 9 HCA Healthcare shares in Q2 2026, an estimated $3.81K.
  • HCA Healthcare made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #400 holding.
  • Clearstead Trust first reported a position in HCA Healthcare in Q2 2017 and has held it in 7 quarters since.
  • Clearstead Trust's HCA Healthcare position peaked at $118K in Q2 2017.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.